EM

Elizabeth Molway

Director Of Intellectual Property at Evox Therapeutics

Elizabeth Molway has a diverse work experience in the biotechnology and intellectual property field. Elizabeth began their career as a Trainee Patent Attorney at J A Kemp - Patent and Trade Mark Attorneys in 2015. Elizabeth then worked as a Project Manager at the University of Oxford in 2014, followed by an Analyst role at The Center for Advancement of Sustainable Medical Innovations (CASMI) from 2012 to 2015. Elizabeth's longest tenure was at Chronos Therapeutics, where they served as a Pre-Clinical Project Manager from 2010 to 2014. During their time at Chronos Therapeutics, they were involved in various responsibilities such as patent research, project coordination, data analysis, and publication editing, among others. Most recently, Elizabeth worked at Evox Therapeutics Ltd as an Associate Director of IP, starting in 2018. Elizabeth also held roles as IP Team Lead and Patent Attorney at the same company.

Elizabeth Molway has a diverse education history. In 2005, they pursued a Masters in Molecular and Cellular Biochemistry from the University of Oxford, specializing in Bionanotechnology, Molecular Oncology, and Neurodegenerative Disease. Following this, in 2012, they completed a course on Fundamentals of Pharmacology from the Perelman School of Medicine at the University of Pennsylvania, via Coursera. In 2013, they enrolled in various online courses, including Drug Discovery, Development & Commercialization from UC San Diego, Healthcare Innovation and Entrepreneurship from Duke University, Fundamentals of Clinical Trials from Harvard Medical School through Edx, and Data Management for Clinical Research from Vanderbilt University, all via Coursera. In 2016, they earned a Certificate in UK Intellectual Property Law from Queen Mary University of London. Currently, they are attending the European Patent Institute, with their expected completion in 2021.

Links

Timeline

  • Director Of Intellectual Property

    July 1, 2023 - present

  • Associate Director Of IP

    July, 2022

  • IP Team Lead

    January, 2020

  • Patent Attorney

    September, 2018

View in org chart